GLP-1 and Fertility: What to Know Before Trying to Get Pregnant
What is the connection between GLP-1 and fertility, and can medications like Ozempic affect ovulation, egg quality, or pregnancy?
Dr. Natalie Crawford explains how GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound work, and why they may improve ovulation for some people with insulin resistance, metabolic dysfunction, or PMOS (formerly PCOS). She also breaks down what “Ozempic babies” really mean, whether GLP-1s directly improve egg quality, when to stop treatment before trying to conceive, and what new observational research involving more than 36,000 pregnancies can and cannot tell us about GLP-1 exposure during pregnancy.
Timestamps:
00:00 GLP-1 and fertility: What you need to know
00:36 What are GLP-1 medications and how do they work?
01:12 How Ozempic and GLP-1s affect your body
03:09 Can GLP-1s improve fertility and ovulation?
04:54 Do GLP-1 medications improve egg quality?
05:20 Why are people talking about “Ozempic babies”?
06:00 GLP-1 birth control and trying to conceive
06:30 Are GLP-1 medications safe during pregnancy?
07:24 How strong is the new GLP-1 pregnancy research?
08:15 What if you get pregnant while taking Ozempic?
08:33 Should you take a GLP-1 before pregnancy?
GLP-1 and fertility are connected through your metabolic health
GLP-1 stands for glucagon-like peptide-1. It is a peptide your small intestine naturally produces after you eat. Think of it as part of your body’s fed-state communication system. Food has arrived, and GLP-1 helps send that message to your brain, stomach, pancreas, and other tissues.
GLP-1 receptor agonists mimic that signal and remain active longer than your natural GLP-1 response. This medication class includes semaglutide, sold under brand names such as Ozempic and Wegovy, as well as tirzepatide, sold as Mounjaro and Zepbound.
Although these medications are primarily used for conditions such as type 2 diabetes and obesity, the same metabolic pathways they affect can also influence reproductive function.
The brain: Your reproductive command station
GLP-1 receptors are found in the hypothalamus, the part of the brain I like to call the command station. It is constantly interpreting information from throughout your body.
The hypothalamus also helps control the release of gonadotropin-releasing hormone, or GnRH. That signal eventually affects FSH and LH, the hormones involved in estrogen production, progesterone production, and ovulation.
In the appetite centers of the brain, GLP-1 medications may increase fullness while reducing hunger, cravings, and what many people describe as food noise.
The stomach: Fullness, digestion, and side effects
GLP-1 medications slow gastric emptying, which means food remains in your stomach longer. That contributes to feeling full and may help reduce rapid rises in blood sugar.
It also explains some of the most common side effects, including nausea, bloating, and reflux. These side effects matter when you are preparing for pregnancy because adequate nutrition is still essential. Rapid weight loss, persistent vomiting, or difficulty meeting your nutritional needs should be discussed with your prescribing clinician.
The pancreas: Insulin and blood sugar
GLP-1 medications increase insulin secretion when it is needed and suppress glucagon, a hormone that tells your liver to release stored glucose.
The resulting improvement in blood sugar regulation can help reduce insulin resistance. That is where the fertility conversation becomes especially relevant.
Insulin resistance: The connection between GLP-1s and ovulation
Insulin is essential. The problem is not that your body makes insulin. The problem develops when your cells stop responding efficiently, forcing your body to release more.
High insulin levels can affect the ovaries. In response, ovarian theca cells may produce more androgens. Those hormonal changes can interfere with follicle development, brain-ovary communication, and ovulation.
This pattern is common in PCOS, but insulin resistance is not limited to people with PCOS. You may have metabolic dysfunction even if you have never received that diagnosis.
Improving insulin sensitivity can reduce the amount of insulin your body needs. For some people, that may lower androgen levels and support more regular ovulation.
Research in women with PCOS has found associations between GLP-1 treatment and improvements in metabolic markers. Some earlier studies also reported improved menstrual regularity and natural pregnancy rates. However, more recent reviews have emphasized that the reproductive evidence remains limited and inconsistent. The most reliable conclusion is that GLP-1s can improve weight-related and metabolic outcomes in some women with PCOS. We still need stronger research to understand exactly how often those changes lead to better reproductive outcomes.
That nuance is important. A medication may improve the environment in which ovulation happens without functioning as a direct ovulation-induction or fertility medication.
GLP-1 medications and PCOS: Who may notice a fertility change?
People with PCOS are among those most likely to notice changes in their menstrual cycles after improving insulin resistance.
If you were not ovulating regularly before treatment and your metabolic health improves, ovulation may become more consistent. That can create an opportunity for pregnancy, including an unexpected pregnancy.
This is one reason a history of infertility should not be treated as contraception. If you do not want to become pregnant while taking a GLP-1, talk with your clinician about an effective contraceptive plan.
Medication details also matter. Tirzepatide may reduce the effectiveness of oral hormonal contraceptives during treatment initiation and after dose increases. Current FDA labeling advises people using oral hormonal contraception to switch to a non-oral method or add a barrier method for four weeks after starting tirzepatide and for four weeks after each dose escalation.
Do not assume every GLP-1 has the same interaction profile. Ask specifically about the medication you are taking.
Do GLP-1 medications improve egg quality?
This is one of the most common questions I hear, and the honest answer is that we do not know.
GLP-1 receptors exist in reproductive tissues, including the ovaries and endometrium. That gives researchers a biologically plausible reason to study whether these medications have direct reproductive effects.
But biological plausibility is not proof.
We do not currently have human studies showing that GLP-1 medications directly improve egg quality. We also cannot look at an individual egg and assign it a simple quality score based on whether someone took Ozempic or another GLP-1.
What we can say is that inflammation, insulin resistance, and metabolic dysfunction are all part of the environment in which an egg develops. Improving those factors may support reproductive function. That is different from claiming that the medication makes eggs healthier.
Age-related changes in egg number and chromosome health also cannot be reversed by losing weight or taking a GLP-1. Metabolic health matters, but it does not erase reproductive aging.
“Ozempic babies”: Why unexpected pregnancies may happen
“Ozempic babies” is a social media phrase, not a medical diagnosis. It refers to reports of people becoming pregnant while taking medications such as Ozempic, sometimes after years of irregular ovulation or infertility.
These pregnancies do not prove that Ozempic is a fertility drug.
A more likely explanation is that some people begin ovulating more consistently after losing weight, improving insulin sensitivity, reducing inflammation, or lowering androgen levels. Fertility may return before the person realizes her cycle has changed.
If you have gone months or years without becoming pregnant, it is easy to assume that the same pattern will continue. But your reproductive physiology can change when your metabolic health changes.
If pregnancy is not your goal, have a contraception plan. If pregnancy is your goal, talk with your prescribing clinician before you begin trying so you can create a safe stopping and preconception plan.
GLP-1 and pregnancy: What does the new research show?
GLP-1 medications have traditionally been stopped before pregnancy because human safety data were limited and animal studies raised concerns about fetal harm.
Newer observational research offers some reassurance, particularly for people who become pregnant unexpectedly while taking one.
A systematic review discussed in the video included four observational studies and 36,963 pregnancies. Compared with other diabetes treatments, GLP-1 exposure was associated with lower odds of gestational diabetes and preterm birth. Researchers did not detect a significant increase in major congenital malformations.
Those findings sound encouraging. They need to be interpreted carefully.
Observational data: Reassuring, but not proof of safety
Observational research looks at what happened among people who received different treatments in real-world settings. Researchers do not randomly assign one group of pregnant women to take a GLP-1 and another group to avoid it.
That means the groups may differ in meaningful ways.
In the review discussed in the episode, the GLP-1 group was older and more likely to have obesity, but less likely to have type 2 diabetes. Diabetes itself can increase the risk of birth defects, preterm delivery, and other complications. Differences in underlying health can therefore influence the results.
Exposure was also limited. Approximately 80% of the people classified in the GLP-1 group stopped treatment before pregnancy, and relatively few continued into the first trimester.
More recent pooled human data have likewise found no statistically significant increase in major congenital malformations, pregnancy loss, stillbirth, or preterm birth. However, researchers continue to describe the certainty of this evidence as low. These studies provide cautious reassurance after inadvertent exposure. They do not establish that routine GLP-1 use during pregnancy is safe.
When should you stop a GLP-1 before pregnancy?
Make a medication-specific plan with the clinician prescribing your GLP-1 and the clinician managing your reproductive care.
For semaglutide products such as Wegovy, current FDA labeling advises stopping at least two months before a planned pregnancy because semaglutide remains in the body for a long time.
Other GLP-1 medications have different half-lives and prescribing information. A universal two-month rule should not be applied to every medication without checking the specific product.
Your plan may also depend on why you take the medication. Someone using a GLP-1 for type 2 diabetes may need another strategy to maintain blood sugar control. Stopping without a plan could leave an important medical condition untreated.
If you are preparing for pregnancy, ask:
Which medication am I taking, and how long does it remain in my body?
When should I take my final dose before trying to conceive?
How will we manage my blood sugar, appetite, or metabolic health after I stop?
Do I need laboratory testing before pregnancy?
Are my prenatal vitamin and nutrition plan appropriate?
What should I do if I become pregnant sooner than expected?
What if you become pregnant while taking Ozempic or another GLP-1?
First, contact your prescribing clinician and pregnancy care clinician promptly. Do not make decisions based only on social media stories.
Current human evidence is reassuring because it has not demonstrated a statistically significant increase in major birth defects after inadvertent exposure. Still, reassuring data are not the same as proof of no risk.
Your clinician can help you decide when to stop the medication, review the timing and amount of exposure, manage the condition for which it was prescribed, and determine whether any additional monitoring is appropriate.
An accidental exposure does not automatically mean that a pregnancy has been harmed. It also does not mean you should continue treatment without individualized medical guidance.
So what do you actually DO with this information?
If you take a GLP-1 and do not want to become pregnant
Use effective contraception and revisit your plan whenever your dose or medication changes. If you take tirzepatide and rely on an oral hormonal contraceptive, ask about the medication-specific FDA guidance.
Past infertility does not guarantee that pregnancy cannot happen now.
If you take a GLP-1 and want to become pregnant
Talk with your clinicians before trying. Identify the exact medication, create an appropriate washout plan, and decide how you will support your metabolic health after stopping it.
Do not wait for a positive pregnancy test to begin this conversation.
If you have PCOS or irregular ovulation
Ask whether insulin resistance may be part of your reproductive picture. A complete plan may include nutrition, movement, sleep, medication, ovulation assessment, and fertility treatment when appropriate.
GLP-1 therapy is one possible metabolic tool. It is not a substitute for a fertility evaluation when one is indicated.
If you became pregnant unexpectedly while taking a GLP-1
Contact your clinician. The available human data offer cautious reassurance, but your care should account for the medication, timing of exposure, dosage, and underlying medical condition.
Frequently asked questions about GLP-1 and fertility
Can Ozempic help you get pregnant?
Ozempic is not approved as a fertility treatment. Some people may begin ovulating more regularly after metabolic health and insulin sensitivity improve, particularly in the setting of PCOS or insulin resistance. That may increase the opportunity for pregnancy.
Can GLP-1 medications improve egg quality?
There is no human evidence showing that GLP-1 medications directly improve egg quality. They may influence metabolic factors associated with reproductive function, but that is not the same as changing the chromosome health of an egg.
Can you take a GLP-1 while trying to conceive?
Current guidance generally recommends stopping GLP-1 medications before pregnancy. The appropriate timing depends on the specific medication and why you take it. Semaglutide labeling recommends stopping at least two months before a planned pregnancy.
Are GLP-1 medications safe during pregnancy?
Available observational evidence is cautiously reassuring after inadvertent exposure, but it does not prove safety or support routine use during pregnancy. Speak with your doctor about your individual medication and medical needs.
Can you get pregnant while taking Ozempic?
Yes. If treatment leads to more regular ovulation, pregnancy may become possible even after a history of irregular cycles or infertility. Do not rely on past difficulty conceiving as contraception.
What are “Ozempic babies”?
The phrase describes pregnancies reported by people taking Ozempic or similar medications. It does not mean Ozempic directly improves eggs or functions as a fertility drug.
The bottom line
GLP-1 medications can affect pathways that matter for fertility, including insulin sensitivity, inflammation, androgen levels, and ovulation. The potential benefit appears most relevant for people whose reproductive dysfunction is connected to PCOS or metabolic health.
They have not been proven to directly improve egg quality. They are not established fertility medications. And although new pregnancy data are reassuring, they have not changed the recommendation to plan medication discontinuation before pregnancy.
If pregnancy is part of your future, bring it into the conversation before you begin trying. Know which medication you take, understand your contraception or washout plan, and make sure the condition being treated remains appropriately managed.
Watch the full video for my complete explanation of GLP-1 medications, fertility, “Ozempic babies,” egg quality, and the newest pregnancy research.
Understand your hormones, optimize your health, and take charge of your fertility with my science-backed guide, The Fertility Formula: https://www.nataliecrawfordmd.com/book
Sources
GLP-1 receptor agonists and pregnancy outcomes: systematic review and meta-analysis
GLP-1 receptor agonists, pregnancy rates, and menstrual cyclicity in PCOS
2026 systematic review of GLP-1 treatment in women with PCOS
Disclaimer: Natalie Crawford, MD, is a doctor, but she is not your doctor. This article is for general education and is not a substitute for individualized medical care.